In Intractable Epilepsy, Stereoelectroencephalography Shows Success Over Subdural Implants
March 8th 2019SEEG displayed better procedural morbidities and may have better outcomes than subdural grid electrodes, which study authors suggest should impact decision-making and lower the surgical candidacy barrier.
OnabotulinumtoxinA sBLAs for Upper, Lower Limb Spasticity Accepted by FDA
March 7th 2019The Allergan product was granted Priority Review for upper limb spasticity and is expected to be decided on in the second quarter of 2019, while the lower limb indication will have its evaluation by the fourth quarter.
Predicting Multiple Sclerosis Progression, Lesion Activity With Machine and Deep Learning
March 5th 2019The director of the probabilistic vision group and medical imaging lab at McGill University spoke about machine learning’s potential to help physicians predict MS disease progression, treatment effectiveness, and more.
Cervical Cord Atrophy May Be Indicative of Progression to Secondary Progressive MS
March 5th 2019The spinal cord area has shown a strong link to MS disability and can help discriminate progressive and relapsing-remitting disease subtypes, which in turn could help inform individualized treatment plans.
Cladribine Associated With Long-Term Sustained NEDA-3 Status in MS
March 2nd 2019A pair of poster presentations regarding the use of cladribine in multiple sclerosis have shown that No Evidence of Disease Activity-3 status can be sustained up to 4 years, without any new safety signals appearing.
Are Neurologists Adhering to Multiple Sclerosis Treatment Guidelines?
March 2nd 2019Data have suggested that neurologists treating MS have clearly and persistently deviated from the readily available evidence regarding DMT use, all while costs continue to rise and payers intensify efforts to control them.
Rare Neurologic Diseases Are Not Truly Rare
February 28th 2019Despite being labeled as rare diseases, a number of neurologic conditions impact more patients than most would believe. The consultant with expertise in ophthalmology, gene therapy, and rare and orphan diseases, chimed in about how these diseases can often be overlooked.
Addressing the Challenges in Determining Pediatric Brain Death
February 27th 2019The pediatric critical care medicine attending physician in the Department of Anesthesiology and Critical Care Medicine at the Children’s Hospital of Philadelphia spoke about how physicians can better address brain death in pediatric patients.
In Parkinson Disease, Levodopa-Induced Dyskinesia is Linked to Frontal Dysfunction Progression
February 27th 2019Investigators concluded that the findings are suggestive of a link between faster cognitive decline, especially frontal lobe dysfunction, in patients with Parkinson who develop levodopa-induced dyskinesia.
Natalizumab, Rituximab More Effective for MS Patients Who Switch from Interferon, Glatiramer Acetate
February 25th 2019The investigators wrote that these findings are suggestive of a superior effect of natalizumab and rituximab compared with fingolimod in suppressing further disease activity in patients with RRMS who switched from interferon or glatiramer acetate due to breakthrough disease.